Resilience and coping as defenders or drivers of symptom severity following mild traumatic brain injury. (22045)
Objectives: Resilience and adaptive coping strategies may mitigate the impact of psychological distress on symptom severity after mild traumatic brain injury (mTBI). This study investigates how resilience and coping styles moderate the relationship between acute psychological distress and symptom severity at 3-, 6-, and 12-months post injury.
Methods: 31 participants (13F, 36.6±13.5y) recruited ≤7d post-mTBI as part of the Concussion REcovery STudy completed self-reports: Depression Anxiety and Stress Scale-21 (total: psychological distress), Brief Resilience Scale (low: ≥x̄-1SD, high: ≥x̄+1SD) and Utrecht Coping List (coping styles: active, passive, avoidant, palliative, emotion, social, reassuring thoughts). Post-Concussion Symptom Scale total scores (PCSS) at 3-(n=30), 6-(n=29) and 12-months (n=28) determined severity.
Findings: Elevated distress at ≤7d post-injury predicted greater PCSS scores at 3-(β=0.754, p<0.001), 6-(β=0.486, p=0.022) and 12-months (β=0.438, p=0.026). Hayes PROCESS assessed moderating influences of resilience and coping style. Resilience moderated distress effects at 3-months (b=0.0538, p<0.05); low resilience increased PCSS scores (b=0.734, p<0.001), high resilience mitigated these effects. At all levels, resilience moderated increased 6-month PCSS scores (b=0.4054, p<0.05). Lower passive coping increased influence of distress, worsening 6-month PCSS scores (b=1.233, p=0.008). Higher emotion-based coping augmented effects of distress intensifying 3-month PCSS scores (b=1.141, p<0.001). Neither resilience nor coping style moderated relationships at 12-months.
Conclusions: Psychological distress at the time of injury increases vulnerability to elevated long-term symptoms. Resilience and coping style may buffer or exacerbate this relationship depending on recovery stage. Implementing early interventions focused on fostering adaptive coping strategies could be critical in attenuating symptom severity and improving long-term outcomes.